Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forest Neurotech
Cambridge, Massachusetts, United Statesforestneurotech.org ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Forest Neurotech has developed a minimally invasive ultrasound-based brain-computer interface ("Forest 1") designed to image and modulate whole-brain activity. The first-in-human clinical study will begin in March 2025 at Barking, Havering and Redbridge University Hospitals NHS Trust to assess safety/tolerability. The technology aims to enable new treatments for conditions such as depression, addiction, OCD, Parkinson’s disease, epilepsy/seizures—especially where current therapies are inadequate. No published efficacy results yet; preclinical data suggest potential for precise deep-brain imaging/modulation with less invasiveness than electrode implants.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceUltrasound-based brain-computer interfaceSoftware platform for neuroimaging and neuromodulation
- Industry
- Academic Hospital/University/Research
02
Partnerships
Butterfly Network – five-year co-development/licensing agreement for semiconductor ultrasound chip technology powering the BCI devices ($20M value over five years)Barking Havering & Redbridge University Hospitals NHS Trust – site of first human trial funded by ARIA UK.
Beyond the preview
Go deeper on Forest Neurotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Forest Neurotech.